AIM
$0.71
AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States.
Historical Price
Peer Comparison
Whystock Valuation Model
Fundamentals
AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. Its flagship products are Ampligen (rinta...
Recent News
Are Medical Stocks Lagging AIM ImmunoTech (AIM) This Year?
Here is how AIM ImmunoTech Inc. (AIM) and Cullinan Therapeutics (CGEM) have performed compared to their sector so far this year.
AIM ImmunoTech Files Preliminary Prospectus for Rights Offering
AIM ImmunoTech (AIM) on Friday filed a preliminary prospectus with the US Securities and Exchange Co
Is AIM ImmunoTech (AIM) Stock Outpacing Its Medical Peers This Year?
Here is how AIM ImmunoTech Inc. (AIM) and Alzamend Neuro, Inc. (ALZN) have performed compared to their sector so far this year.
Zacks.com featured highlights include The Honest Company, Dutch, AIM ImmunoTech, Masimo and Cognizant Technology Solutions
HNST, BROS, AIM, MASI, and CTSH are spotlighted as top-ranked stocks with rising P/E ratios and strong earnings momentum.
Bet On 5 Top-Ranked Stocks With Rising P/E
Tap these five stocks with increasing P/E ratios to try out an out-of-the-box approach. These stocks are The Honest Company, Dutch Bros, AIM ImmunoTech, Masimo and Cognizant Technology Solutions.